(Q33370224)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

review article

1 reference

title

Treatment of heparin-induced thrombocytopenia: is there a role for bivalirudin? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

heparin-induced thrombocytopenia

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Amy L Seybert

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Kristin Zerumsky

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

language of work or name

English

0 references

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

229-241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

Heparin‐induced thrombocytopenia: pathogenesis and management

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Pharmacological properties of hirudin and its derivatives. Potential clinical advantages over heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Monitoring of recombinant hirudin: assessment of a plasma-based ecarin clotting time assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Pharmacokinetic optimisation of the treatment of deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Favorable outcome with bivalirudin anticoagulation during cardiopulmonary bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Anticoagulation with bivalirudin during cardiopulmonary bypass in cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Cardiopulmonary bypass with bivalirudin in type II heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Reversal of direct thrombin inhibition after cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Bivalirudin use in off-pump myocardial revascularization in patients with heparin-induced thrombocytopenia [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Anticoagulation for acute coronary syndromes and percutaneous coronary intervention in patients with heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.2.229

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.2.229

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16466327%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference